Recalls & Warnings September 12, 2012 Distribution of Weight Loss Product Containing DMAA Should Be Stopped Immediately, Warns FDA On August 28, 2012, the FDA issued a warning letter to Regeneca stating that the company's RegeneSlim, which was promoted as a dietary supplement for weight loss, is adulterated with dimethylamylamine (DMAA) and that failure to immediately cease distribution of this product could result in FDA
While results can vary and more human studies are needed to validate many of the claims surrounding BPC-157, the early feedback and preclinical research suggest promising directionsespecially when it comes to natural recovery, resilience, and performance support
BPC 157 normalized MDA and NO-levels in the liver of BDL rats (Sever et al., 2019) and wound-healing response to chronic liver injury that may be accordingly modified (Figure 12) (Albanis and Friedman, 2001
Honest Caveats: What the Research Actually Says I'm a fighter and a trainer, not a doctor